---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-102153"
form_type: "8-K"
ticker: "GRDN"
cik: "0001802255"
company_name: "Guardian Pharmacy Services, Inc."
filed_at: "2026-03-11T23:59:59+00:00"
generated_at: "2026-05-15T14:56:31.940484+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Guardian Pharmacy Q4 revenue $397.6M (+17% YoY), net income $21.3M (+81%); raises 2026 EBITDA guidance

## Summary
- Q4 diluted EPS $0.33, adjusted EPS $0.37; full-year diluted EPS $0.78, adjusted EPS $1.07.
- Full-year revenue $1.45B (+18% YoY); net income $49.0M vs $71.0M loss in 2024.
- 2026 Adjusted EBITDA guidance raised to $120M–$124M (from $115M–$118M); revenue guidance unchanged $1.40B–$1.42B.
- Cash $65.6M at year-end, no long-term debt outstanding under $75M credit facility.
- Annualized return on equity approximately 27% in 2025; 54 full-service pharmacies after North Ridge acquisition.

## SEC filing metadata
- accession: 0001193125-26-102153
- form_type: 8-K
- ticker: GRDN
- cik: 0001802255
- company_name: Guardian Pharmacy Services, Inc.
- filed_at: 2026-03-11T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1802255/000119312526102153/0001193125-26-102153-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1802255/000119312526102153/d47713d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-102153
- JSON: https://secwatch.observer/filing/0001193125-26-102153.json
- Plain text: https://secwatch.observer/filing/0001193125-26-102153.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.